Delivery Order SPE2DB20D3101-SPE2DB25FRRG8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,507.57 to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly prescribed for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,930.56 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Escitalopram 10 mg, a generic selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,581.60 firm fixed-price contract is for the delivery of 10 mg escitalopram tablets, a generic pharmaceutical used to treat depression and anxiety. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for 4,563,955,449 units of the medication Escitalopram 10 mg tablet. The contract has a total ceiling value of $10,658.61 and an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,250 units of the pharmaceutical drug Escitalopram 10 mg tablets. The $1,757.34 contract has a performance period ending on January 8, 2024 and will be executed from Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp has a long history of providing pharmaceutical products and...
- The Defense Logistics Agency Troop Support Medical awarded a $748.73 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 90 tablets of 10mg escitalopram. As the prime contractor, Amerisourcebergen Drug Corp will deliver the generic antidepressant medication to its place of performance in Conshohocken, Pennsylvania within the period of performance between August 10-11, 2023. The delivery order was placed under an existing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.61 firm-fixed-price delivery order is for the supply of 4,558,009,304 tablets of 10 mg Escitalopram, a generic antidepressant medication. The contract has an ultimate completion date of August 8, 2022 and was awarded on August 5, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $1,063.62 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division on June 27, 2023. The order is for 1,000 tablets of the generic antidepressant escitalopram at 10 mg per tablet. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle managed by the Defense...
- The Defense Logistics Agency awarded a $3,065.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of escitalopram, an antidepressant medication. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 31 and September 1, 2023. No...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty thousand one hundred five dollars and sixty-four cents ($20,105.64) to Amerisourcebergen Drug Corporation for the delivery of one thousand (1,000) units of escitalopram tablets, a selective serotonin reuptake inhibitor prescribed for depression and anxiety. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 24-25, 2023. No set aside...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRG8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg on July 29, 2025, with a ceiling value of $2,187.18 and an ultimate completion date of July 30, 2025. The contract carries a firm fixed price with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The current order for Escitalopram, a selective serotonin reuptake inhibitor commonly used to treat depression and anxiety disorders, represents a routine pharmaceutical procurement supporting federal medical supply requirements for defense and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/29/25 |